The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among ...
Ascentage Pharma has announced that its novel BCR-ABL1 tyrosine kinase inhibitor (TKI), olverembatinib, has been ap...
China-based Harvest Integrated Research Organization (HiRO), a full-service, boutique global contract research organisat...
China-based startup Hasten Biopharmaceutical has successfully acquired the asset rights of 14 branded products across Pa...
Porton Advanced, a subsidiary of China headquartered contract development and manufacturing organisation (CDMO) Porton P...
Nasopharyngeal carcinoma (NPC) is a cancer type strongly associated with Epstein-Barr virus (EBV) infection. The Chinese...
China-based biotech company MGI Tech Co. has partnered with France-based startup SeqOne, a leading provider of AI-powere...
US-based firm AbbVie and FutureGen Biopharmaceutical (Beijing) have announced a license agreement to develop FG-M701, a ...
France-headquartered Ethypharm has announced the acquisition of a suppository form of Mesalazine by its Chinese affiliat...
The signing ceremony for the Peking University Health Science Center (PKUHSC)-Boehringer Ingelheim Joint Laboratory of H...
CPHI & PMEC China (June 19-21st) returns to the Shanghai New International Expo Center amid soaring demand across th...
A team led by Dr Billy SO, core member of the Research Institute for Sports Science and Technology (RISports) and A...
US-based InDevR, Inc., a leading provider of analytical tools for vaccine quality control and testing, has teamed up wit...
China-headquartered DAMO Academy, Alibaba Group’s research institute, has announced its partnership with the WHO C...
China-headquartered MGI Tech Co. has announced the opening of its new European headquarters in Berlin, Germany ...
A research team led by Professor Elmer Ker, Assistant Professor in the School of Biomedical Sciences at The Chinese...
Novotech, Australia-headquartered clinical Contract Research Organization (CRO) that partners with biotech companies to ...
By 2040, the burden of colorectal cancer (CRC) is projected to increase to 3.2 million new cases and 1.6 million deaths ...
